SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-002062
Filing Date
2021-01-29
Accepted
2021-01-29 09:00:22
Documents
54
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 364229
2 ex31-1.htm EX-31.1 19965
3 ex31-2.htm EX-31.2 20219
4 ex32-1.htm EX-32.1 6575
5 ex32-2.htm EX-32.2 7453
  Complete submission text file 0001493152-21-002062.txt   2223100

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vbio-20201231.xml EX-101.INS 320671
7 XBRL SCHEMA FILE vbio-20201231.xsd EX-101.SCH 39447
8 XBRL CALCULATION FILE vbio-20201231_cal.xml EX-101.CAL 40524
9 XBRL DEFINITION FILE vbio-20201231_def.xml EX-101.DEF 62989
10 XBRL LABEL FILE vbio-20201231_lab.xml EX-101.LAB 231040
11 XBRL PRESENTATION FILE vbio-20201231_pre.xml EX-101.PRE 152303
Mailing Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067
Business Address 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA 90067 530-231-7800
Vitality Biopharma, Inc. (Filer) CIK: 0001438943 (see all company filings)

IRS No.: 753268988 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-53832 | Film No.: 21568346
SIC: 8731 Services-Commercial Physical & Biological Research